NL
TMO icon

NWAM LLC’s Thermo Fisher Scientific TMO Stock Holding History

NWAM LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
3,953
+714
+22% +$343K 0.1% 209
2026
Q1 		$1.59M Sell
3,239
-269
-8% -$146K 0.09% 210
2025
Q4 		$2.19M Sell
3,508
-888
-20% -$502K 0.12% 170
2025
Q3 		$2.38M Buy
4,396
+634
+17% +$295K 0.13% 166
2025
Q2 		$1.75M Buy
+3,762
New +$1.57M 0.1% 193
2025
Q1 		– Sell
-4,667
Closed -$2.43M – 598
2024
Q4 		$2.43M Sell
4,667
-1,647
-26% -$906K 0.15% 147
2024
Q3 		$3.91M Buy
+6,314
New +$3.74M 0.24% 95
2024
Q2 		– Sell
-2,769
Closed -$1.59M – 497
2024
Q1 		$1.59M Sell
2,769
-12
-0.4% -$6.73K 0.13% 159
2023
Q4 		$1.48M Buy
2,781
+72
+3% +$34.9K 0.12% 171
2023
Q3 		$1.37M Sell
2,709
-535
-16% -$285K 0.14% 149
2023
Q2 		$1.69M Buy
3,244
+504
+18% +$272K 0.14% 145
2023
Q1 		$1.58M Buy
2,740
+48
+2% +$27.1K 0.16% 133
2022
Q4 		$1.48M Buy
2,692
+91
+3% +$48.2K 0.13% 166
2022
Q3 		$1.32M Sell
2,601
-1,341
-34% -$750K 0.13% 168
2022
Q2 		$2.15M Sell
3,942
-96
-2% -$52.8K 0.2% 107
2022
Q1 		$2.38M Buy
4,038
+599
+17% +$344K 0.18% 121
2021
Q4 		$2.29M Buy
3,439
+631
+22% +$394K 0.18% 128
2021
Q3 		$1.6M Buy
2,808
+1,388
+98% +$762K 0.15% 159
2021
Q2 		$716K Sell
1,420
-110
-7% -$51.9K 0.07% 251
2021
Q1 		$698K Buy
1,530
+1,007
+193% +$481K 0.07% 253
2020
Q4 		$244K Buy
+523
New +$245K 0.03% 387
2020
Q3 		– Sell
-1,687
Closed -$611K – 410
2020
Q2 		$611K Buy
+1,687
New +$565K 0.09% 214
2019
Q4 		$262K Buy
+808
New +$245K 0.05% 328

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NWAM LLC's TMO Position: Q2 2026 in Review

NWAM LLC increased its Thermo Fisher Scientific (TMO) stake by 22% in Q2 2026, buying an estimated $343K and bringing the position to 3,953 shares worth $1.98M. The position accounts for 0.1% of the portfolio, ranked #209.

NWAM LLC first reported a position in TMO in Q4 2019 and has held it in 23 quarters since. The position peaked at $3.91M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • NWAM LLC held 3,953 shares of Thermo Fisher Scientific worth $1.98M as of Q2 2026.
  • NWAM LLC bought 714 Thermo Fisher Scientific shares in Q2 2026, an estimated $343K.
  • Thermo Fisher Scientific made up 0.1% of NWAM LLC's portfolio in Q2 2026, its #209 holding.
  • NWAM LLC first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 23 quarters since.
  • NWAM LLC's Thermo Fisher Scientific position peaked at $3.91M in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.